MedPath
HSA Approval

DONCEPT F.C. TABLET 5MG

SIN15086P

DONCEPT F.C. TABLET 5MG

DONCEPT F.C. TABLET 5MG

September 13, 2016

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N06DA02

donepezil

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Actavis Ltd.

Active Ingredients

Donepezil Hydrochloride Monohydrate eqv. Donepezil Hydrochloride

5mg

Donepezil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DONCEPT F.C. TABLET 5MG - HSA Approval | MedPath